# Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/surufatinib-in-advanced-pancreatic-neuroendocrine-tumours-sanet-p-a-randomised/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jianming Xu,Lin Shen,Chunmei Bai,Wei Wang,Jie Li,Xianjun Yu,Zhiping Li,Enxiao Li,Xianglin Yuan,Yihebali Chi,Yongmei Yin,Wenhui Lou,Nong Xu,Yuxian Bai,Tao� Zhang,Dianrong Xiu,Xiuwen Wang,Ying Yuan,Jia Chen,Shukui Qin,Ru Jia,Ming Lu,Yuejuan Cheng,Zhiwei Zhou,Jing Li,James Jun He,Weiguo Su |
| Citations | 194 |
| DOI | 10.1016/s1470-2045(20)30493-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3087238097 |
| PMID | 32966810 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Jia Chen](https://scholariq.org/researchers/jia-chen/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Paper topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.